<DOC>
	<DOCNO>NCT00596882</DOCNO>
	<brief_summary>The propose study design examine effect message prim genetic susceptibility actual enrollment smoke cessation program , actual response smoke cessation treatment , potential moderator mediator effect .</brief_summary>
	<brief_title>Message Priming Enrollment , Response , Smoking Cessation Program : A Pilot Study</brief_title>
	<detailed_description>Despite available behavioral pharmacological intervention treat nicotine dependence , smoker utilize intervention . As , vast majority smoker capitalize potentially effective nicotine dependence treatment . The way health risk information present may influence interest smoking cessation program . In series preliminary study , individual provide message prim role genetic variation susceptibility addiction smoking exhibit positive consequence intention quit ( Cappella , Lerman , Romantan , &amp; Baruh , 2005 ) . The propose study design examine effect message prim genetic susceptibility actual enrollment smoke cessation program , actual response smoke cessation treatment , potential moderator mediator effect . The result pilot study may provide preliminary data large trial implication design intervention promote utilization effective treatment nicotine dependence among smoker .</detailed_description>
	<criteria>Eligible participant 100 male &amp; female smoker age 1865 , smoke ≥ 10 cigarettes/day &amp; plan live area next 6months . Key Exclusion Criteria Smoking Behavior 1.Use chew tobacco snuff 2.Current enrollment plan enroll another smoking cessation program next 6 month 3.Plan use nicotine substitute smoke cessation treatment next 6 month Alcohol/Drug Exclusion Criteria 1 . History substance abuse and/or currently receive treatment substance abuse 2 . Current alcohol consumption exceed &gt; 25 standard drinks/week Medication Exclusion Criteria 1 . Current use recent discontinuation ( within last 14days ) follow medication : 1 . Any form smoking cessation medication 2 . Any form antipsychotic medication include : •antipsychotics , •atypical antipsychotic , •moodstabilizers , •antidepressants ( tricyclic , SSRI 's , MAOI 's ) , •antipanic agent , •antiobsessive agent , •antianxiety agent , stimulant ( e.g. , Provigil , Ritalin ) . 3 . Medication chronic pain 4 . Anticoagulants 5 . Any heart medication 6 . Daily medication asthma Medical Exclusion Criteria 1 . Women pregnant , planning pregnancy , lactate . 2 . History current diagnosis psychosis , major depression bipolar disorder , schizophrenia , Axis 1 disorder . 3 . Serious/unstable disease within past 6 month ( e.g. , cancer [ melanoma ] , heart disease , HIV ) . 4 . History epilepsy seizure disorder . 5 . History current diagnosis ( last 6months ) abnormal rhythm and/or tachycardia ( &gt; 100 beats/minute ) ; history current diagnosis COPD , cardiovascular disease ( stroke , angina , coronary heart disease ) , heart attack last 6 month , uncontrolled hypertension ( SBP &gt; 150 DBP &gt; 90 ) . 6 . History kidney and/or liver failure ( include transplant ) . General Exclusion 1 . Any medical condition concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . 2 . Inability provide inform consent complete study task determine Principal Investigator and/or Study Physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>nicotine dependence</keyword>
	<keyword>message prime</keyword>
	<keyword>recruitment</keyword>
</DOC>